Form4insider filings, from the source

SEC Form 4 · accession 0000908662-18-000165

ReShape Lifesciences Inc. · RSLS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Dec 19, 2017
Accepted (ET)
Jun 5, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.01 per shareF1,F2,F3Dec 19, 2017C136,580—A174,472D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series C Convertible Preferred Stock, par value $0.01F5,F3,F2,F4—Dec 19, 2017C20,487DDec 19, 2017—Common Stock136,58026,200D

Explanation of responses